Significance and prevalence of Tamoxifen related endometrial changes in patients of carcinoma breast

IJSRP, Volume 4, Issue 3, March 2014 Edition [ISSN 2250-3153]

Significance and prevalence of Tamoxifen related endometrial changes in patients of carcinoma breast

Marcus S. MD, DNB., Mahajan MK. MD, MNAMS, Grover S. MD, DNB, DGO, 4Sachdev J. MD, Jeyaraj P. MD, Mukhopadhyay S. MD

Abstract: Tamoxifen acts as an estrogen agonist on the female genital tract. The side effect of major concern is endometrial carcinoma.

[VIEW FULL PAPER]

[DOWNLOAD]

[Reference this Paper] [BACK]

Reference this Research Paper (copy & paste below code):

Marcus S. MD, DNB., Mahajan MK. MD, MNAMS, Grover S. MD, DNB, DGO, 4Sachdev J. MD, Jeyaraj P. MD, Mukhopadhyay S. MD (2018); Significance and prevalence of Tamoxifen related endometrial changes in patients of carcinoma breast; Int J Sci Res Publ 4(3) (ISSN: 2250-3153). http://www.ijsrp.org/research-paper-0314.php?rp=P272430